http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#Head
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#provenance
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#pubinfo
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://identifiers.org/MONDO:0021668
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/CHEBI:119915
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
http://www.w3.org/2000/01/rdf-schema#label
ABSTRALĀ® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain.
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
https://w3id.org/biolink/vocab/provided_by
NeuroDKG
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
https://w3id.org/biolink/vocab/publications
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e60f00e9-2cf4-4c20-b570-1c2ea426c8c7
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort
http://www.w3.org/2000/01/rdf-schema#label
cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort
https://schema.org/requiredMinAge
18
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Cohort
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort
https://w3id.org/biolink/vocab/has_phenotype
https://identifiers.org/MONDO:0005070
https://identifiers.org/CHEBI:119915
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
https://identifiers.org/MONDO:0021668
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#provenance
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#pubinfo
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig
http://purl.org/nanopub/x/hasSignature
KDxCEQgTVz+3euJPPQludpB26SPYwtqnb9Pqdch5GxDKyoM9wvVJbvhwJJn/jHp9gRg+gT0fajxiAbb63rxwLykXoYS1dn3JWjtv8eQsIQpSiSEqmIDwTZSo/oTUe0g0iiPVnpkiBILk1DfnTEBATLraqgmK1FNZ3bct77uveM4=
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://purl.org/dc/terms/created
2021-03-28T20:19:13.984+02:00
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI